• ABOUT GBR

  • AEROSPACE

  • CHEMICALS

  • MINING

  • PHARMACEUTICALS

INTERVIEWS MORE INTERVIEWS

Ocugen explains its work on cures for unmet needs in the ophthalmology space and COVID-19 vaccine development.
Famar explains how it will continue develop capabilities so as to accompany its customers through clinical phases with clinical batches, scale-up, and ultimately manufacturing and packaging.
Tosk explains how it is successfully developing drugs to counter the side effects of cancer therapies.

ARTICLES

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

The Global Tailings Standard

April 16, 2021
The mining industry and investment community are collaborating to mitigate a perpetual risk, after a series of high-profile disasters.

Tailings Management

April 16, 2021
Expert Opinion Article by Dan Etheredge, General Manager, Klohn Crippen Berger S.A.

Optimism Returns to Peru’s Mining Sector

March 21, 2021
Surging copper brings renewed optimism to Peru, but a pivotal election looms.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Pharmaceuticals & Biopharmaceuticals 2021

PARTNER EVENTS